Claret wins Debt Funding Deal of the Year (<€10M) at the Irish Investor Awards 2026 with Neurent Medical

We’re delighted to have won Debt Funding Deal of the Year (<€10M) at the Irish Investor Awards 2026 for our investment in Neurent Medical.

Neurent is a great example of the innovation emerging from Ireland’s medtech sector. We’re proud to support the team with tailored, low-dilution growth capital as they continue to scale and commercialise NEUROMARK®, a minimally invasive solution to treat chronic rhinitis.

Thank you to the judges and the Irish Investor Awards team for the recognition.